References
- Graham D.J.M., Dow R.J., Freedman D., Mroszczak E., Ling T. Pharmacokinetics of nicardipine following oral and intravenous administration in man. Postgraduate Medical Journal 1984; 60(Suppl. 4)7–10
- Higuchi S., Shiobara Y. Comparative pharmacokinetics of nicardipine hydrochloride, a new vasodilator in various species. Xenobiotica 1980a; 10: 447–454
- Higuchi S., Shiobara Y. Metabolic fate of nicardipine hydrochloride, a new vasodilator, by various species, in vitro. Xenobiotica 1980b; 10: 889–896
- Higuchi S., Shiobara Y. Application of the stable isotope technique to the elucidation of the saturation phenomenon of nicardipine hydrochloride metabolising enzyme activity in dogs. Biomedical Mass Spectrometry 1980c; 7: 339–344
- Higuchi S., Sasaki H., Shiobara Y., Sado T. Absorption, excretion and metabolism of a new dihydropyridine diester cerebral vasodilator in rats and dogs. Xenobiotica 1977; 7: 469–479
- Medenwald H., Schlossmann K., Wünsche C. Strukturaufklarung der renalen aus scheidungsprodukte von 4-(2-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarbonsaure-dimethyl ester. Arzneimittel-Forschung 1972; 22: 53–56
- Parker S., Weinstock J. Biotransformation of 1,4-dihydro-2,6-dimethyl-4-(2-trifluoromethylphenyl)-3,5-pyridine dicarboxylic acid diethyl ester. Journal of Medical Chemistry 1973; 16: 34–37
- Shibanuma T., Iwanami M., Fujimoto M., Takenaka T., Murakami M. Synthesis of the metabolites of 2-(N-Benzyl-N-methylamino) ethyl methyl-2–6-dimethyl-4-(meta-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride (nicardipine hydrochloide, YC-93). Chemical and Pharmaceutical Bulletin 1980; 28: 2609–2613
- Takenaka T., Usuda S., Nomura T., Maeno H., Sado T. Vasodilator profile of a new 1,4-dihydropyridine derivative, 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid-3-(2-N-benzyl-N-methylamino))-ethyl ester 5-methyl ester hydrochloride (YC-93). Arzneimittel-Forschung 1976; 26: 2172–2178
- Terai M., Takenaka T., Maeno H. Inhibition of calcium influx in rabbit aorta by nicardipine hydrochloride (YC-93). Biochemical Pharmacology 1980; 30: 375–378
- Walkenstein S., Intoccia A., Flanagan T., Hwang B., Flint D., Weinstock J., Villani A., Blackburn D., Green H. Metabolism of the antihypertensive agent, 1,4-dihydro-2,6-dimethyl-4-(2-trifluoromethylphenyl)-3,5-pyridine dicarboxylic acid diethyl ester. Journal of Pharmaceutical Sciences 1973; 62: 580–584
- Walle U.K., Wilson M.J., Walle T. Propranolol, alprenolol and oxprenolol metabolism in the dog. Identification of N-methylated metabolites. Biomedical Mass Spectrometry 1981; 8: 78–84
- Weidolf L., Borg K.O., Hoffman K.-J. Urinary metabolites of felodipine, a new vasodilator drug, in man, dog, rat and mouse. Xenobiotica 1984; 14: 657–666
- Wu A.T., Massey I.J., Kushinsky S. A high performance liquid chromatographic method for the simultaneous determination of nicardipine and its pyridine metabolite II in plasma. Journal of Pharmaceutical Sciences 1984; 73: 1444–1447